$GENE OSCIENT PHARMACEUTICALS CORP Insider Trading
Get free email notifications about insider trading in OSCIENT PHARMACEUTICALS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OSCIENT PHARMACEUTICALS CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in OSCIENT PHARMACEUTICALS CORP for free.
CIK Number: 0000356830
IRS Number: 042297484
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GENE
Company Address: 1000 WINTER STREET SUITE 2200 WALTHAM 02451
Former name: COLLABORATIVE RESEARCH INC, date of change: 1992-07-03
Former name: GENOME THERAPEUTICS CORP, date of change: 1994-12-15
Market Capitalization: $13.04M
Prev close: $1.13
Average Daily Volume: 784,831
Days Low: $1.08
Year Low: $1.04
Year High: $2.89
OSCIENT PHARMACEUTICALS CORP Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2009 | GENE | OSCIENT PHARMACEUT ... | BB BIOVENTURES L P | 10% Owner | Buy | C | 1.10 | 4,222 | 4,644 | 4,222 | 0 to 4.2 K |
May 26 2009 | GENE | OSCIENT PHARMACEUT ... | GLG Partners LP | 10% Owner | Sell | S | 0.30 | 785,616 | 236,942 | 73,923 | 859.5 K to 73.9 K (-91.40 %) |
May 15 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.21 | 468,230 | 98,141 | 0 | 468.2 K to 0 (-100.00 %) |
May 15 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.23 | 108,162 | 24,921 | 468,230 | 576.4 K to 468.2 K (-18.77 %) |
May 15 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.25 | 416,391 | 104,473 | 576,392 | 992.8 K to 576.4 K (-41.94 %) |
May 13 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Buy | C | 0.00 | 992,783 | 0 | 992,783 | 0 to 992.8 K |
May 12 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.27 | 100,325 | 27,409 | 0 | 100.3 K to 0 (-100.00 %) |
Apr 01 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.13 | 70,000 | 8,897 | 100,325 | 170.3 K to 100.3 K (-41.10 %) |
Apr 01 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.13 | 150,000 | 19,065 | 170,325 | 320.3 K to 170.3 K (-46.83 %) |
Mar 27 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.13 | 200,000 | 26,040 | 320,325 | 520.3 K to 320.3 K (-38.44 %) |
Mar 27 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.13 | 160,269 | 20,162 | 520,325 | 680.6 K to 520.3 K (-23.55 %) |
Mar 27 2009 | GENE | OSCIENT PHARMACEUT ... | DellaCamera Capital Management ... | 10% Owner | Sell | S | 0.18 | 967,939 | 178,682 | 680,594 | 1.6 M to 680.6 K (-58.72 %) |
Jul 30 2008 | GENE | OSCIENT PHARMACEUT ... | Glickman Mark A | SVP, Sales & Market ... | Option Exercise | A | 1.48 | 15,000 | 22,125 | 15,000 | |
Jul 30 2008 | GENE | OSCIENT PHARMACEUT ... | Glickman Mark A | SVP, Sales & Market ... | Grant | A | 0.00 | 10,000 | 0 | 36,157 | 26.2 K to 36.2 K (+38.23 %) |
Jun 13 2008 | GENE | OSCIENT PHARMACEUT ... | BROWN GREGORY B | Director | Option Exercise | A | 1.77 | 750 | 1,328 | 750 |